Skip to content
Politically.com Search all
Menu

2025 · 2nd Quarter (Apr 1 - June 30)

ARUP LABORATORIES, INC.

Filed by VAN SCOYOC ASSOCIATES.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 18, 2025
Income
$30,000.00
Expenses
Not reported
Filing UUID
468da994-a7d6-4e02-8e59-874cbf542870
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

Monitor the following: Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues H.R.1, One Big Beautiful Bill Act, generally

Literal federal measure citations: H.R.1

HCR · Health Issues

FDA regulation, Laboratory Testing related issues Clinical Laboratory Improvement Amendments (CLIA), Modernization generally Monitor the following: Prescription drug costs, generally Protecting Access to Medicare Act, Laboratory payment policies VALID Act, Diagnostic Lab Testing Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues

MED · Medical/Disease Research/Clinical Labs

FDA regulation, Laboratory Testing related issues Clinical Laboratory Improvement Amendments (CLIA), Modernization generally Monitor the following: Prescription drug costs, generally Protecting Access to Medicare Act, Laboratory payment policies VALID Act, Diagnostic Lab Testing Public Law 117-328, Consolidated Appropriations Act, FY2023, Lab Infrastructure issues; and Diagnostic Lab Testing related issues

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.